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Clinical Case Report
ABSTRACT
Renal cell carcinoma (RCC) is a malignant disease that is often diagnosed at a metastatic stage. The head and neck 
represent up to 3% of the metastatic RCC, and the paranasal sinus area is one of the least involved sites. Here, we 
introduce the case of a 74-year-old female patient who presented with a history of traumatic nasal bleed. A cranial 
computed tomography scan and magnetic resonance imaging showed a fronto-ethmoidal mass with pachymeningeal 
involvement. A nasal biopsy from the paranasal sinuses was taken. On histopathological examination, metastatic clear 
cell carcinoma was the main hypothesis, which later was confirmed to be RCC on immunohistochemistry. On further 
radiological examination, an exophytic mass was depicted in the kidney’s upper and middle pole. The patient had no 
renal complaints and was asymptomatic. Fronto-ethmoidal sinus is a rare site for metastatic RCC, especially in cases 
where the patient is asymptomatic. Early detection by keeping RCC metastasis as the differential diagnosis in such cases 
can lead to early treatment and improve the overall survival of the patient. 
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INTRODUCTION
Renal cell carcinoma (RCC) accounts for 90% of 
all renal malignancies1 and is more common among 
middle-aged and elderly men.2 The most common 
sites are the lung (76%), regional lymph nodes (66%), 
bone (42%), and liver (41%).3 Paranasal sinuses are 
a rare site for RCC to metastasize.4 Thus, metastatic 
carcinoma to the paranasal sinuses of the primary site 
in the kidney is a rare diagnosis that should be raised in 
asymptomatic middle-aged patients presenting with a 
unilateral paranasal sinus mass and epistaxis. We report 
the case of fronto-ethmoidal sinus involvement by 
metastatic RCC in an asymptomatic and undiagnosed 
RCC patient.
CASE REPORT
A 74-year-old female patient presented with 
complaints of nasal bleeding after a road traffic 
accident. On clinical examination, a growth in the nasal 
cavity was visualized using a zero-degree endoscope. 
Contrast-enhanced magnetic resonance imaging 
depicted irregular soft tissue in the frontal and ethmoid 
sinuses projecting into the left nasal cavity, and the 
left orbital apex. A breach of the frontal sinus boney 
walls and intracranial extension with thickening of 
the pachymeninges was also noted. A punch biopsy 
was undertaken from the left intranasal growth under 
general anesthesia after decongesting the nasal cavity 
with adrenaline and saline (1:4). The biopsy was sent 
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for histopathological examination, which revealed a 
neoplasia composed of clear vacuolated cells arranged 
in sheets, cords, and trabeculae, highly vascular, with 
numerous interspersed thin-walled blood vessels. 
No distinct cell borders, cell membrane thickening, 
or any raisin-like nuclei were seen (Figure 1A). 
On immunohistochemical examination, the tumor cells 
were strongly positive for RCC antigen (Figure 1B), 
vimentin (Figure 1C), panCK and EMA (Figure 1D), 
but showed negativity for smooth muscle actin, CD34, 
CD 31, CD10, HMB-45, and S-100, PAX-8 and CK 7.
Based on the pat ient ’s  morphology and 
immunohistochemistry, the possibility of metastatic 
RCC was indicated. On further evaluation, the computed 
tomography (CT) urography revealed an exophytic and 
necrotic lesion measuring 7 cm in its longest axis over 
the upper and mid pole of the left kidney. Also, the 
imaging study showed tumor infiltration of the left 
renal vein with a thrombus formation. Meanwhile, 
the patient had an episode of massive epistaxis 
followed by a myocardial infarction (MI), but with a 
good outcome. After clinical stabilization, the patient 
was referred to medical oncology and was started on 
pazopanib 800 mg once daily for 30 days. Currently, 
she is doing well and is asymptomatic.
DISCUSSION
RCC is most commonly seen in the age group 
of 30–60 years and is routinely present with flank 
pain, palpable mass, and gross hematuria.5 It shows 
a variable growth rate, and metastases may be found 
anywhere in the body. The most common sites are 
the lung (76%), regional lymph nodes (66%), bone 
(42%), and liver (41%).3 RCC metastasis to the head 
and neck—specifically in the paranasal sinuses—is 
rare.6,7 Only 100 cases have been reported so far 
to our knowledge. In these cases, ethmoid sinus 
Figure 1. A – A tumor comprised of clear cells arranged in clusters. The cells have abundant clear-to-vacuolated 
cytoplasm and a central round nucleus showing mild pleomorphism. Nucleoli are inconspicuous (H&E 400X). 
B – Tumor cells showing strong membranous staining with RCC antigen (400X). C – Tumor cells showing strong 
membranous staining with vimentin. D – Tumor cells showing no staining with SMA (400X). RCC = renal cell 
carcinoma; SMA = smooth muscle actin.
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(50%) was the most common site for metastasis, 
followed by maxillary sinus (39%), sphenoid sinus 
(19%), and frontal sinus. In 21 cases, the diagnosis 
of metastasis was made before the primary tumor 
was diagnosed.6 The most common route for 
distant metastasis is by the bloodstream, especially 
through the renal vein.8 The maxillary sinuses are 
more frequently affected by the RCC metastatic 
tumor, followed by the ethmoid sinus, frontal and 
sphenoid.9 The paranasal sinuses are a rare location of 
metastasis; however, the most frequent primary tumor 
to metastasize to paranasal sinuses is RCC.2 Tumors 
great than 3 cm are more prone to cause metastasis 
and microvascular thrombi formation, which may lead 
to increased incidence of MI.10
As our patient was stable with no cardiovascular 
impairment, the episode of MI could have been due to 
atherosclerosis considering her age; however, in view 
of the distant metastasis to the paranasal sinuses and 
the size of the tumor, tumor thromboembolism should 
be ruled out. RCC with paranasal sinus metastasis 
as the first presenting sign is rare. Clinically, RCC 
metastasis to the fronto-ethmoidal sinuses may 
present with nasal bleeding; this raised the suspicion in 
our case along with the mass.11 A concomitant history 
of trauma may lead to the wrong approach; therefore, 
detailed clinical and histopathological examinations 
were of vital importance. Histological features should 
be complemented with the immunohistochemical 
markers. RCC is positive for panCK, RCC antigen, 
and vimentin. CK7 is positive in papillary renal cell 
carcinoma but negative in clear cell carcinoma12 In 
the case of metastatic RCC it is crucial to confirm 
the renal origin of the tumor by using PAX-8. In our 
case, tumor cells’ morphology favored clear cell 
carcinoma with strong immunopositivity for RCC 
antigen, vimentin, panCK, and EMA. Tumor cells were 
negative for CK7, thus ruling out the papillary renal 
cell carcinoma. In our case PAX-8 lost its expression at 
the metastatic site, and thus was negative. Although 
PAX-8 expression is frequently positive in most of the 
clear cell RCC, loss of its expression does not rule out 
the renal origin of the tumor.13 Thus, in such cases, 
the morphology as well as immunohistochemical 
findings, should be contemplated with the clinic-
radiological findings.
CONCLUSION
RCC metastasis presenting as epistaxis is rare, 
and a detailed examination via urinalysis, intravenous 
pyelogram, and CT is required in case of suspicion. 
In these cases, epistaxis is usually present. The precise 
diagnosis will always depend on the histopathological 
examination along with ancillary techniques.
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